Afsaneh Jahani

Afsaneh Jahani

Auto-generated profile, based on publicly available information

Afsaneh Jahani

Orthopedic Research Center, Department of Orthopedic Surgery, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2025 in Nano LIFE
Verified
Journal Article
Closed access
NJNafiseh Jirofti
Nafiseh Jirofti
FSFarkhonde Sarhaddi
Farkhonde Sarhaddi
AJAfsaneh Jahani
Afsaneh Jahani
Abbas RahdarAbbas Rahdar
Abbas Rahdar
FKFatemeh Kalalinia
Fatemeh Kalalinia
SPSadanand Pandey
Sadanand Pandey

16 July 2025 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
AJAfsaneh Jahani
Afsaneh Jahani
MNMehrnoush Nakhaei
Mehrnoush Nakhaei
AMAli Moradi
Ali Moradi
MEMohammad Ali Ebrahimzadeh
Mohammad Ali Ebrahimzadeh
MMMahnaz Sadat Mirbagheri
Mahnaz Sadat Mirbagheri
NJNafiseh Jirofti
Nafiseh Jirofti

25 March 2025 in Journal of Tissue Viability
Verified
Journal Article
Open access
AJAfsaneh Jahani
Afsaneh Jahani
DMDavod Mohebbi-Kalhori
Davod Mohebbi-Kalhori
FSFarkhonde Sarhaddi
Farkhonde Sarhaddi
GKGholam Hosein Kazemzadeh
Gholam Hosein Kazemzadeh
RTReza Taheri
Reza Taheri
NJNafiseh Jirofti
Nafiseh Jirofti
Tissue engineering and regenerative medicine aim to address tissue lesions and organ degenerations, enhancing clinical outcomes by restoring damaged tissues and functionalities. Recent progress in materials science and medicine has led to the development of regenerative engineering, revolutionizing the production of polymeric artificial scaffolds by electrospinning method, which mimic the extracellular matrix (ECM). Polyurethane (PU) is recognized for its elastic nature, comprising soft and hard segments, and possesses bioactive as well as biocompatible properties. Polycaprolactone (PCL), on the other hand, is a non-toxic polymer with a viscous nature, known for its favorable mechanical properties. This study focuses on the comprehensive histological evaluation of binary electrospun PET-based nanofiber scaffolds, as widely used in tissue engineering. The structural analysis involved FE-SEM imaging, porosity measurement, FTIR, and DSC examinations. In vitro assessments included degradation rates, water uptake, cell viability, morphological cell examination, and cell attachment studies. Additionally, scaffolds were subcutaneously implanted in rats for pathological examination. After a 30 days implantation period, histological and pathological parameters such as edema, inflammation, foreign body giant cell reaction, fibrosis, necrosis, and calcification were evaluated. The results highlight the successful application of blend electrospinning in producing PET/PCL and PET/PU nanofiber scaffolds with various composition ratios. FE-SEM imaging revealed uniform nanostructures without bead formation. Histological analysis showed favorable biocompatibility, with the PET/PCL (25:75) composition demonstrating superior structural characteristics compared to other ratios. The cell studies indicated that PET-based nanofiber scaffolds exhibited suitable cell viability and attachment, underscoring their potential for tissue engineering applications.

30 September 2025 in Knee Surgery & Related Research
Verified
Journal Article
Open access
PDF file
AJAfsaneh Jahani
Afsaneh Jahani
MEMohammad Ali Ebrahimzadeh
Mohammad Ali Ebrahimzadeh
MDMohsen Dehghani
Mohsen Dehghani
MSMaedeh Sharafoddin
Maedeh Sharafoddin
AMAli Moradi
Ali Moradi
NJNafiseh Jirofti
Nafiseh Jirofti
Background: Meniscal injuries, involving damage to the critical fibrocartilaginous structure of the knee joint, often necessitate surgical intervention, including meniscal allograft transplantation or the use of commercial implants. Despite advances in implant based therapies, there is no consensus regarding the comparative efficacy of collagen meniscus implants (CMI) versus polyurethane-based (PU-based) scaffolds. This review aimed to systematically evaluate and compare the clinical outcomes associated with these two implant types for partial meniscal repair. Methods: A comprehensive systematic review was conducted to evaluate the clinical outcomes of meniscal implants by searching multiple databases including Medline/PubMed, Web of Science, Embase, Scopus, and Cochrane in the temporal range of 1999–2024. The review focused on pre–post studies and assessed various patient-reported outcome measures, including the visual analog scale (VAS), international Knee Documentation Committee (IKDC), Lysholm, knee injury and osteoarthritis outcome score (KOOS), as well as the Tegner activity score. These outcomes were evaluated across different follow-up periods [short-term (6 month to 2.5 years), mid-term (2.5–5 years) and long-term (10 years)] following meniscal implant implantation. A random-effects meta-analysis model was used to address heterogeneity, along with a sensitivity analysis to evaluate the robustness of pooled estimates. The National Institutes of Health (NIH) quality assessment tool was utilized to assess the methodological quality in the studies. Results: The meta-analysis identified 26 studies that met the inclusion criteria, and the overall quality of the included studies was mostly fair to good. The analysis showed that both CMI and PU-based scaffolds improved clinical outcomes in patients with partial meniscus injuries, with the implants evaluated across short-term, mid-term, and long-term follow-up periods. Specifically, the analysis found: the VAS scores significantly improved during the short-term follow-up by an average of −1.86 points for CMI and −1.98 points for PU-based scaffolds. Lysholm scores significantly improved at short-term follow-up, increasing by an average of 29.26 points for CMI and 24.98 points for PU-based scaffolds. For the Tegner score, CMI implants showed an average increase of 2.02 points in the short-term, while PU-based implants exhibited a negligible change of −0.05 points. Conclusions: Both CMI and PU-based scaffolds demonstrated improved clinical outcomes, but showed some differences in effectiveness over follow-up periods. PU-based scaffolds offer faster integration and short-term effectiveness, while CMI promotes gradual tissue regeneration and long-term stability. Although these differing characteristics support personalized meniscal repair strategies, the lack of comparative studies limits definitive clinical guidance. Level of evidence: Level III, IV.

4 November 2025 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Open access
PDF file
MMMohaddese Mohaddesi
Mohaddese Mohaddesi
AJAfsaneh Jahani
Afsaneh Jahani
DMDavod Mohebbi-Kalhori
Davod Mohebbi-Kalhori
GKGholam Hosein Kazemzadeh
Gholam Hosein Kazemzadeh
RTReza Taheri
Reza Taheri
NJNafiseh Jirofti
Nafiseh Jirofti
The development of small-diameter vascular grafts (SDVGs) remains a significant challenge and unsolved problem due to issues with compliance mismatch, thrombosis, and graft failure. This study explores electrospun blended scaffolds made from polyethylene terephthalate (PET) and polyurethane (PU), both Food and Drug Administration (FDA)-approved polymers, as potential candidates for small-diameter vascular applications. Nanofibrous scaffolds composed of blended PET and PU were fabricated using the electrospinning method. The morphological and chemical properties of the scaffolds were characterized by FE-SEM, porosity measurement, FTIR, and DSC. Comprehensive mechanical evaluations, including tensile strength, burst pressure, and compliance, were performed. Biocompatibility was assessed by examining cellular adhesion, proliferation, and viability on the scaffolds. For in vivo evaluation, the electrospun scaffolds were subcutaneously implanted in rats. The PET/PU blended scaffolds exhibited excellent physicochemical compatibility, with mechanical properties within the range of native small-diameter blood vessels (SDBVs). Burst pressure and compliance evaluations demonstrated the ability of the PET/PU blend to mitigate the compliance mismatch commonly observed in synthetic grafts. Additionally, the scaffolds supported strong human cell adhesion, proliferation, and high cell viability, indicating good biocompatibility. No signs of necrosis, calcification, severe fibrosis, inflammation, or foreign body granulomatous reaction were observed following subcutaneous implantation of the scaffolds. Electrospun PET/PU scaffolds offer promising mechanical and biocompatible properties for SDVGs applications. The ability to address compliance mismatch, combined with excellent cellular support, positions these scaffolds as a strong candidate for clinical use. However, further preclinical and clinical studies are necessary to validate their long-term safety, performance, and commercial viability.

3 February 2025 in Carbohydrate Polymer Technologies and Applications
Verified
Journal Article
Open access
AJAfsaneh Jahani
Afsaneh Jahani
MNMohammad Sadegh Nourbakhsh
Mohammad Sadegh Nourbakhsh
AMAli Moradi
Ali Moradi
MMMarzieh Mohammadi
Marzieh Mohammadi
LTLobat Tayebi
Lobat Tayebi